At its core, the goal of this experimental HIV vaccine is the same as the vaccines for COVID: block the spikes on the virus so it can’t infect cells. The problem is that HIV’s spikes are constantly mutating.
Despite the complex challenges, researchers are hopeful about some day making a vaccine that could help your immune system prevent or treat HIV and AIDS.
Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday.
Human clinical trials have started for an experimental HIV vaccine that uses the same kind of mRNA technology found in Moderna’s successful COVID-19 vaccine, the drug company announced this week.